News & Analysis as of September 20, 2024

Inventors › Mylan Pharmaceuticals

+ Follow

John Harmon on the Evolving Impact of Artificial Intelligence on Intellectual Property
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions (Podcast)
From an Artistic Eye to AI, Building Bristles into a Buzzworthy Company with Tina Tang
Cases Updated in CNIPA Guidelines - Eligibility & Inventiveness for AI & Business Method Applications
PODCAST: Williams Mullen's Trending Now: An IP Podcast - Five Popular Misconceptions about Patents
Episode #11 - Successful Serial Entrepreneurship with Seth Burgett
Nonpublication Requests For Patent Applications Part 3: Pitfalls
What Is a Patent and How Do I Get One
Nonpublication Requests For Patent Applications Part 1: Benefits
[IP Hot Topics Podcast] Innovation Conversations: Dr. Claire Fraser
Monthly Minute | Commercialization of an Invention
JONES DAY PRESENTS®: Artificial Intelligence: The Growing Role of AI on Patents
Hedy Lamarr - When Beauty and Brains Collide (Women's History Month)
Pepper Hamilton Higher Education "In Brief" Webinar Series: Intellectual Property Basics - What Every Higher Education Administrator Needs To Know
Podcast: Artificial Intelligence and Intellectual Property Considerations
Protecting IP Through Employment Law
Earn-Out Arrangements – Interview with David Lagasse, Member, Mintz Levin
Polsinelli Podcast - Emerging Technology & Startup Companies
Instapundit: America's IP Laws Need to be "Pruned Back"

Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)

McDonnell Boehnen Hulbert & Berghoff LLP on 12/8/2023

Proper construction of claim limitations reciting the chemical property of pH (which denotes the concentration of hydrogen ions in a solution as an indication of acidity) has arisen several times in district court and Federal...more

1 Results

View per page

Page: of 1

Inventors › Mylan Pharmaceuticals

Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)

"My best business intelligence, in one easy email…"